When it comes to pre-revenue biotechs, it's often a struggle to build an investment thesis beyond "if the medicine works, the ...

Detailed price information for Yum China Holdings Inc (YUMC-N) from The Globe and Mail including charting and trades.

The biggest risk is competition in the growing GLP-1 marketplace. The latest news is that Viking Therapeutics' VK2735 ...